Insider Shareholders with Direct Ownership of Catalent, Inc. (CTLT)
This section provides a comprehensive overview of the insiders with direct ownership of Catalent, Inc. (CTLT). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Catalent, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
John R Chiminski
Executive Chair |
697,536 | 771,613 | 229,888 $14.6 Million | 18 |
Aug 25, 2022
Reduced 14.48%
|
|
Steven L Fasman
EVP & Chief Admin Officer |
98,338 | 100,971 | 73,789 $4.68 Million | 23 |
Aug 24, 2023
Reduced 1.1%
|
|
Jonathan Arnold
SVP, CCO & Div. Head BioP Del. |
71,671 | 53,130 | 57,399 $3.64 Million | 20 |
Aug 24, 2023
Reduced 0.15%
|
|
Wetteny Joseph
SVP & Chief Financial Officer |
5,000 | 9,776 | 49,823 $3.16 Million | 4 |
Feb 16, 2021
Reduced 1.97%
|
|
Ricardo Pravda
Chief Transformation Officer |
30,281 | 11,756 | 30,224 $1.92 Million | 18 |
Aug 24, 2023
Reduced 1.24%
|
|
Madhavan Balachandran
Director |
14,669 | 0 | 27,441 $1.74 Million | 4 |
Oct 27, 2023
Added 20.31%
|
|
Michael J Grippo
SVP, Strategy & Corp. Dev. |
23,489 | 17,546 | 24,449 $1.55 Million | 22 |
Aug 24, 2023
Reduced 1.57%
|
|
Karen Flynn
Director |
12,538 | 5,049 | 24,339 $1.55 Million | 7 |
Oct 27, 2023
Added 22.32%
|
|
Rosemary A Crane
Director |
14,669 | 0 | 23,873 $1.52 Million | 4 |
Oct 27, 2023
Added 22.66%
|
|
Thomas P Castellano
SVP, Chief Financial Officer |
14,248 | 6,716 | 20,099 $1.28 Million | 10 |
Aug 25, 2022
Reduced 6.57%
|
|
Christa Kreuzburg
Director |
14,669 | 3,026 | 18,283 $1.16 Million | 9 |
Jan 25, 2024
Reduced 2.78%
|
|
Kay A Schmidt
SVP, Enterprise Functions |
8,729 | 10,090 | 17,388 $1.1 Million | 13 |
Aug 25, 2022
Reduced 7.06%
|
|
Manja Boerman
Pres. BioModalities Division |
6,676 | 5,522 | 14,414 $915,000 | 4 |
May 01, 2023
Reduced 9.12%
|
|
Peter Zippelius
Director |
7,676 | 0 | 11,979 $760,426 | 3 |
Oct 27, 2022
Added 25.73%
|
|
Charles Lickfold
SVP, CIO |
5,959 | 325 | 11,339 $719,799 | 4 |
Aug 24, 2023
Reduced 1.65%
|
|
Patricia Hunt
Pres. Consumer Health Div |
3,190 | 628 | 11,267 $715,229 | 7 |
Oct 16, 2023
Reduced 0.19%
|
|
Lorenzo Carletti
SVP Global Ops Ph & Cons Hlth |
7,429 | 2,263 | 8,746 $555,196 | 8 |
Aug 24, 2023
Reduced 2.41%
|
|
Thomas W Hawkeswood
Pres. Pharma Prod Delivery Div |
3,827 | 2,006 | 7,533 $478,194 | 7 |
Aug 24, 2023
Reduced 1.91%
|
|
Michael A. Riley
Pres. Bio Product Delivery Div |
3,973 | 3,973 | 6,592 $418,460 | 3 |
Aug 26, 2022
Reduced 27.42%
|
|
Ricardo Zayas
SVP, Operations, Biologics NA |
4,435 | 0 | 6,223 $395,036 | 1 |
Aug 01, 2023
Added 41.61%
|
|
Mario Gargiulo
SVP, Ops, Biologics Europe |
4,269 | 3,351 | 5,676 $360,312 | 6 |
May 01, 2023
Reduced 10.67%
|
|
Karen Murphy Santiago
VP & Chief Accounting Officer |
4,763 | 0 | 4,763 $302,355 | 2 |
Aug 01, 2023
Added 32.96%
|
|
Ricci S Whitlow
President, CSS |
531 | 959 | 2,923 $185,552 | 4 |
Jan 21, 2022
Reduced 5.92%
|
| 12,635 | 12,635 | 0 $0 | 4 |
Dec 18, 2024
Reduced 100.0%
|
|
| 12,635 | 12,635 | 0 $0 | 4 |
Dec 18, 2024
Reduced 100.0%
|
|
|
Aristippos Gennadios
Group Pres. Pharma & Consumer |
106,164 | 156,395 | 0 $0 | 24 |
Dec 18, 2024
Reduced 100.0%
|
|
Scott Gunther
SVP, Quality & Reg. Affairs |
55,843 | 73,933 | 0 $0 | 27 |
Dec 18, 2024
Reduced 100.0%
|
|
Ricky Hopson
Pres. BioProduct Delivery, CoS |
39,902 | 53,127 | 0 $0 | 25 |
Dec 18, 2024
Reduced 100.0%
|
|
Alessandro Maselli
President & CEO |
297,796 | 315,659 | 0 $0 | 19 |
Dec 18, 2024
Reduced 100.0%
|
| 19,332 | 36,914 | 0 $0 | 6 |
Dec 18, 2024
Reduced 100.0%
|
|
|
Lisa Evoli
SVP, Chief HR Officer |
27,370 | 55,257 | 0 $0 | 4 |
Dec 18, 2024
Reduced 100.0%
|
|
Matti Masanovich
SVP, Chief Financial Officer |
151,159 | 151,159 | 0 $0 | 5 |
Dec 18, 2024
Reduced 100.0%
|
| 12,374 | 12,374 | 0 $0 | 4 |
Dec 18, 2024
Reduced 100.0%
|
|
|
John J Greisch
Executive Chair |
104,942 | 113,462 | 0 $0 | 6 |
Dec 18, 2024
Reduced 100.0%
|
| 19,887 | 35,870 | 0 $0 | 8 |
Dec 18, 2024
Reduced 100.0%
|
|
| 19,332 | 47,984 | 0 $0 | 6 |
Dec 18, 2024
Reduced 100.0%
|
|
| 19,332 | 70,118 | 0 $0 | 6 |
Dec 18, 2024
Reduced 100.0%
|
|
| 19,332 | 47,984 | 0 $0 | 6 |
Dec 18, 2024
Reduced 100.0%
|
|
| 18,052 | 18,052 | 0 $0 | 6 |
Dec 18, 2024
Reduced 100.0%
|
|
|
Joseph Anthony Ferraro
SVP, General Counsel, CCO |
39,160 | 39,160 | 0 $0 | 7 |
Dec 18, 2024
Reduced 100.0%
|
|
Michael Hatzfeld
Chief Accounting Officer |
16,676 | 16,676 | 0 $0 | 4 |
Dec 18, 2024
Reduced 100.0%
|
| 13,635 | 13,635 | 0 $0 | 6 |
Dec 18, 2024
Reduced 100.0%
|
|
|
David Mc Erlane
Group President, Biologics |
30,172 | 49,724 | 0 $0 | 4 |
Dec 18, 2024
Reduced 100.0%
|